Free Trial

SeaStar Medical (ICU) Competitors

$0.22
0.00 (0.00%)
(As of 06/7/2024 ET)

ICU vs. NVNO, SEPA, STIM, APYX, LNSR, CTCX, CTSO, CODX, NUVO, and XAIR

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include enVVeno Medical (NVNO), SEP Acquisition (SEPA), Neuronetics (STIM), Apyx Medical (APYX), LENSAR (LNSR), Carmell (CTCX), Cytosorbents (CTSO), Co-Diagnostics (CODX), Holdco Nuvo Group D.G (NUVO), and Beyond Air (XAIR). These companies are all part of the "surgical & medical instruments" industry.

SeaStar Medical vs.

enVVeno Medical (NASDAQ:NVNO) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.

In the previous week, SeaStar Medical had 3 more articles in the media than enVVeno Medical. MarketBeat recorded 4 mentions for SeaStar Medical and 1 mentions for enVVeno Medical. SeaStar Medical's average media sentiment score of 1.63 beat enVVeno Medical's score of -0.50 indicating that enVVeno Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
enVVeno Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

enVVeno Medical has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.03, meaning that its stock price is 203% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SeaStar Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

enVVeno Medical received 155 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote.

CompanyUnderperformOutperform
enVVeno MedicalOutperform Votes
156
62.65%
Underperform Votes
93
37.35%
SeaStar MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes

enVVeno Medical is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
enVVeno MedicalN/AN/A-$23.52M-$1.66-2.82
SeaStar MedicalN/AN/A-$26.23M-$1.00-0.22

enVVeno Medical's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
enVVeno MedicalN/A -62.17% -57.58%
SeaStar Medical N/A N/A -725.48%

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 17.0% of enVVeno Medical shares are owned by company insiders. Comparatively, 3.0% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

enVVeno Medical beats SeaStar Medical on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$16.55M$3.91B$5.26B$8.17B
Dividend YieldN/A1.79%2.74%4.04%
P/E Ratio-0.2215.23140.1218.13
Price / SalesN/A72.862,403.0666.88
Price / CashN/A48.3435.3931.03
Price / Book-0.884.314.984.32
Net Income-$26.23M$4.50M$110.61M$216.21M
7 Day Performance-40.93%-1.00%-1.08%-1.44%
1 Month Performance-50.07%-0.39%-0.68%-0.60%
1 Year Performance-57.02%-18.40%2.90%3.53%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVNO
enVVeno Medical
0.2915 of 5 stars
$4.68
-4.3%
N/A+80.3%$65.18MN/A-2.8219News Coverage
Positive News
SEPA
SEP Acquisition
0 of 5 stars
$9.75
-10.6%
N/A-2.0%$63.38MN/A0.00N/A
STIM
Neuronetics
3.4225 of 5 stars
$2.24
+10.3%
$8.00
+257.1%
-8.9%$60.90M$71.35M-2.33203Insider Buying
Positive News
Gap Up
APYX
Apyx Medical
4.3097 of 5 stars
$1.60
flat
$6.17
+285.4%
-76.9%$55.43M$52.35M-2.42252Gap Down
LNSR
LENSAR
1.2059 of 5 stars
$4.61
-2.9%
$8.00
+73.5%
+38.9%$54.14M$42.16M-2.92130Gap Down
CTCX
Carmell
0 of 5 stars
$2.56
-1.2%
N/AN/A$53.88MN/A0.009Gap Down
CTSO
Cytosorbents
0.9311 of 5 stars
$0.89
flat
$2.00
+125.2%
-73.2%$48.23M$36.35M-1.51186Gap Up
CODX
Co-Diagnostics
3.4383 of 5 stars
$1.35
-5.6%
$2.00
+48.1%
+26.2%$44.73M$6.81M-1.02155Gap Up
High Trading Volume
NUVO
Holdco Nuvo Group D.G
0 of 5 stars
$1.32
flat
N/AN/A$43.90M$180,000.000.00N/AGap Down
XAIR
Beyond Air
3.292 of 5 stars
$1.17
-0.8%
$10.75
+818.8%
-79.4%$42.53MN/A-0.5598Gap Down

Related Companies and Tools

This page (NASDAQ:ICU) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners